Khiron Life Sciences Corp (TSE:KHRN)

Khiron Life Sciences (KHRN) Financial Statements


Khiron Life Sciences Financial Overview

Khiron Life Sciences's market cap is currently ―. The company's EPS TTM is C$-0.167; its P/E ratio is -0.24; Khiron Life Sciences is scheduled to report earnings on November 29, 2023, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total RevenueC$ 3.38M-C$ 4.64MC$ 3.64MC$ 3.52M
Gross ProfitC$ 1.65M-C$ 1.50MC$ 1.17MC$ 1.81M
EBITC$ -3.45MC$ -4.68MC$ -5.26MC$ -18.39MC$ -4.61M
EBITDAC$ -2.90MC$ -4.28MC$ -4.67MC$ -18.09MC$ -4.26M
Net Income Common StockholdersC$ -3.58M-C$ -5.41MC$ -19.50MC$ -3.34M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 1.94MC$ 0.00C$ 5.13MC$ 8.92MC$ 15.42M
Total AssetsC$ 38.44M-C$ 41.84MC$ 42.27MC$ 66.41M
Total DebtC$ 2.56MC$ 0.00C$ 2.79MC$ 2.23MC$ 1.93M
Net DebtC$ 626.00KC$ 0.00C$ -2.34MC$ -6.70MC$ -13.49M
Total LiabilitiesC$ 11.35M-C$ 12.33MC$ 8.95MC$ 11.41M
Stockholders EquityC$ 27.10MC$ 0.00C$ 29.52MC$ 33.33MC$ 55.01M
Cash Flow-
Free Cash FlowC$ -5.92M-C$ -3.12MC$ -6.30MC$ -5.07M
Operating Cash FlowC$ -5.04M-C$ -2.80MC$ -5.17MC$ -4.85M
Investing Cash FlowC$ -873.00K-C$ -309.00KC$ -1.47MC$ -213.98K
Financing Cash FlowC$ 863.00K-C$ -194.00KC$ 471.10KC$ 11.26M
Currency in CAD

Khiron Life Sciences Earnings and Revenue History

Khiron Life Sciences Debt to Assets

Khiron Life Sciences Cash Flow

Khiron Life Sciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis